Pyrazinamide Susceptibility Is Driven by Activation of the SigE-Dependent Cell Envelope Stress Response in Mycobacterium tuberculosis-Reference-Cited by-同舟云学术

Pyrazinamide Susceptibility Is Driven by Activation of the SigE-Dependent Cell Envelope Stress Response in Mycobacterium tuberculosis

Published:2022-02-22 Issue:1 Volume:13 Page:
ISSN:2150-7511
Container-title:mBio
language:en
Short-container-title:mBio

Author:

Thiede Joshua M.¹,Dillon Nicholas A.¹^ORCID,Howe Michael D.¹,Aflakpui Ranee²,Modlin Samuel J.³^ORCID,Hoffner Sven E.³⁴,Valafar Faramarz³^ORCID,Minato Yusuke¹⁵,Baughn Anthony D.¹^ORCID

Affiliation:

1. Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, Minnesota, USA

2. West African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Accra, Ghana

3. Laboratory for Pathogenesis of Clinical Drug Resistance and Persistence, Biomedical Informatics Research Center, Division of Epidemiology, School of Public Health, San Diego State University, San Diego, California, USA

4. Department of Global Public Health, Karolinska Institute, Stockholm, Sweden

5. Department of Microbiology, Fujita Health University School of Medicine, Toyoake, Japan

Abstract

For decades, pyrazinamide has served as a cornerstone of tuberculosis therapy. Unlike any other antitubercular drug, pyrazinamide requires an acidic environment to exert its action.

Funder

HHS | NIH | National Heart, Lung, and Blood Institute

HHS | NIH | National Institute of Allergy and Infectious Diseases

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mbio.00439-21

Reference73 articles.

1. World Health Organization. 2019. Global tuberculosis report 2019.

2. Controlled clinical trial of four short-course (6-month) regimens of pulmonary tuberculosis: third report;East African/British Medical Research Councils;Lancet,1974

3. A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis

4. Systematic Analysis of Pyrazinamide-Resistant Spontaneous Mutants and Clinical Isolates of Mycobacterium tuberculosis

5. Draft Genome Sequences of Two Pyrazinamide-Resistant Clinical Isolates, Mycobacterium tuberculosis 13-4152 and 13-2459

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Studying the dynamics of the drug processing of pyrazinamide in Mycobacterium tuberculosis;PLOS ONE;2024-08-29

2. Structure of the SigE regulatory network in Mycobacterium tuberculosis;Frontiers in Microbiology;2024-05-30

3. Targeting Mycobacterium tuberculosis pH-driven adaptation;Microbiology;2024-05-08

4. 3D Hydrogel Culture System Recapitulates Key Tuberculosis Phenotypes and Demonstrates Pyrazinamide Efficacy;Advanced Healthcare Materials;2024-05

5. A Microtiter Plate Assay at Acidic pH to Identify Potentiators that Enhance Pyrazinamide Activity Against Mycobacterium tuberculosis;Methods in Molecular Biology;2024